4
Changes in Ownership
MAIA Biotechnology, Inc. Filed Acc 0001127602-25-011813
Options or other derivatives
- Director acquired 26,304 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Louie Ngar Yee Director | 2025-04-04 | Grant or award · Stock Options | +26,304 | 26,304 | D: show line 1 in the form |
Loading xslF345X05/form4.xml…